| Net Cash Provided by (Used in) Operating Activities |
-114K |
USD |
-643% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
113K |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100M |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
94.9M |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.22K |
USD |
+92% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
887K |
USD |
+23% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
887K |
USD |
+23% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Operating Lease, Liability, Current |
0 |
USD |
-100% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0 |
pure |
-89.6% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
791K |
USD |
-21.8% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
10M |
shares |
|
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
27.6M |
USD |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |